In this issue:
Doublet carboplatin/paclitaxel remains the standard of care even in frail patients
Geriatric assessment and management in cancer
HIPEC with carboplatin during secondary cytoreductive surgery for recurrent disease
Secondary cytoreductive surgery in BRCA1/2 mutated recurrent ovarian cancer
NORA confirms efficacy of maintenance PARP inhibition for relapsed disease
Addition of immune checkpoint inhibition to standard frontline regimen does not extend PFS
SOC-1: secondary surgery extends PFS in platinum-sensitive disease at first relapse
A surgical competency assessment tool for sentinel lymph node dissection
REZOLVE indicates that palliative intraperitoneal bevacizumab may be an option for ascites
Are BRCA1/2 mutations a risk factor for endometrial cancer?
Please login below to download this issue (PDF)